Ravix, A.; Bandiera, C.; Cardoso, E.; Lata-Pedreira, A.; Chtioui, H.; Decosterd, L.A.; Wagner, A.D.; Schneider, M.P.; Csajka, C.; Guidi, M.
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study. Cancers 2024, 16, 2193.
https://doi.org/10.3390/cancers16122193
AMA Style
Ravix A, Bandiera C, Cardoso E, Lata-Pedreira A, Chtioui H, Decosterd LA, Wagner AD, Schneider MP, Csajka C, Guidi M.
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study. Cancers. 2024; 16(12):2193.
https://doi.org/10.3390/cancers16122193
Chicago/Turabian Style
Ravix, Anne, Carole Bandiera, Evelina Cardoso, Adrian Lata-Pedreira, Haithem Chtioui, Laurent Arthur Decosterd, Anna Dorothea Wagner, Marie Paule Schneider, Chantal Csajka, and Monia Guidi.
2024. "Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study" Cancers 16, no. 12: 2193.
https://doi.org/10.3390/cancers16122193
APA Style
Ravix, A., Bandiera, C., Cardoso, E., Lata-Pedreira, A., Chtioui, H., Decosterd, L. A., Wagner, A. D., Schneider, M. P., Csajka, C., & Guidi, M.
(2024). Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study. Cancers, 16(12), 2193.
https://doi.org/10.3390/cancers16122193
